subject area of

• A Phase 2 Randomized Study Investigating the Efficacy and Safety of Myostatin Antibody LY2495655 versus Placebo in Patients Undergoing Elective Total Hip Arthroplasty.  Academic Article
• A Phase I Biodistribution and Pharmacokinetic Trial of Humanized Monoclonal Antibody Hu3s193 in Patients with Advanced Epithelial Cancers that Express the Lewis-Y Antigen  Academic Article
• A Possible Role for Metallic Ions in the Carbohydrate Cluster Recognition Displayed by a Lewis Y Specific Antibody  Academic Article
• A phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer  Academic Article
• A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinoma  Conference Paper
• Anti-EGFR therapeutic efficacy correlates directly with inhibition of STAT3 activity  Academic Article
• Antifibrotic Activity of Bevacizumab on Human Tenon's Fibroblasts In Vitro  Academic Article
• Bleb vascularity following post-trabeculectomy subconjunctival bevacizumab: A pilot study  Academic Article
• Cardioprotective Effect of β-Adrenoceptor Blockade in Patients With Breast Cancer Undergoing Chemotherapy: Follow-Up Study of Heart Failure  Academic Article
• Characterization of ABBV-221, a Tumor-Selective EGFR-Targeting Antibody Drug Conjugate  Academic Article
• Characterization of ABT-806, a humanized tumor-specific anti-EGFR monoclonal antibody  Academic Article
• Combined diode laser cyclophotocoagulation and intravitreal bevacizumab (Avastin) in neovascular glaucoma  Academic Article
• Cost-Minimization Analysis of the Treatment of Patients With Metastatic Colorectal Cancer in Greece  Academic Article
• Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: preclinical evaluation and results of the phase II DUX study in chemotherapy-refractory, advanced colorectal cancer  Academic Article
• Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma.  Academic Article
• Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases  Academic Article
• Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study  Academic Article
• Evolution of anti-HER2 therapies for cancer treatment  Academic Article
• Hallmarks of response to immune checkpoint blockade  Academic Article
• Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma  Academic Article
• Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity  Academic Article
• Late presentation of generalised bullous pemphigoid-like reaction in a patient treated with pembrolizumab for metastatic melanoma  Academic Article
• Molecular Imaging and Quantitation of EphA2 Expression in Xenograft Models with Zr-89-DS-8895a  Academic Article
• Molecular imaging of T cell co-regulator factor B7-H3 with 89Zr-DS-5573a  Conference Paper
• Molecular imaging of death receptor 5 occupancy and saturation kinetics in vivo by humanized monoclonal antibody CS-1008  Academic Article
• PIK3CA Mutation/PTEN Expression Status Predicts Response of Colon Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Cetuximab  Academic Article
• PTEN gene expression and mutations in the PIK3CA gene as predictors of clinical benefit to anti-epidermal growth factor receptor antibody therapy in patients with KRAS wild-type metastatic colorectal cancer  Academic Article
• Phase I Biodistribution and Pharmacokinetic Study of Lewis Y-Targeting Immunoconjugate CMD-193 in Patients with Advanced Epithelial Cancers  Academic Article
• Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer  Academic Article
• Population Pharmacokinetics of Sibrotuzumab, A Novel Therapeutic Monoclonal Antibody, in Cancer Patients  Academic Article
• Reproducibility of Echocardiographic Techniques for Sequential Assessment of Left Ventricular Ejection Fraction and Volumes Application to Patients Undergoing Cancer Chemotherapy  Academic Article
• Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma  Academic Article
• Targeted chemoradiation in metastatic colorectal cancer: A phase i trial of 131i-hua33 with concurrent capecitabine  Academic Article
• Targeted therapies for cancer  Academic Article
• Targeting Lewis Y (Ley) in Small Cell Lung Cancer with a Humanized Monoclonal Antibody, hu3S193: A Pilot Trial Testing Two Dose Levels  Academic Article
• Telomere length is a novel predictive biomarker of sensitivity to anti-EGFR therapy in metastatic colorectal cancer  Academic Article
• Therapeutic anti-EGFR antibody 806 generates responses in murine de novo EGFR mutant–dependent lung carcinomas  Academic Article
• Therapeutic efficacy of177Lu-CHX-A″-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy  Academic Article
• Tumor Targeting by a Multivalent Single-Chain Fv (scFv) Anti-Lewis Y Antibody Construct  Academic Article
• Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab  Academic Article
• Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection  Academic Article
• Vascular Changes After Intra-bleb Injection of Bevacizumab  Academic Article
• Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer  Academic Article